Standard Lipid-Lowering Therapy is named as a drug or biological intervention in 2 clinical trials in our China trial register, 2 of which are recruiting. Lead sponsors include West China Hospital (1) and Shanghai Zhongshan Hospital (1). Registered phases: Phase 4 and Not applicable. Conditions studied include Coronary; Coronary Artery Disease; Acute Myocardial Infarction (AMI).
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07612774 | CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS (ClinicalTrials.gov ↗) Coronary, Coronary Artery Disease |
Phase 4 | Recruiting |
| NCT07208006 | Very Early PCSK9 Inhibition for Acute Myocardial Infarction (ClinicalTrials.gov ↗) Acute Myocardial Infarction (AMI) |
Not applicable | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Coronary | 1 |
| Coronary Artery Disease | 1 |
| Acute Myocardial Infarction (AMI) | 1 |
| Lead sponsor | Trials |
|---|---|
| West China Hospital | 1 |
| Shanghai Zhongshan Hospital | 1 |
| Register | Standard Lipid-Lowering Therapy trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Standard Lipid-Lowering Therapy works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Standard Lipid-Lowering Therapy (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.